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Abstract. 
 
Osteoclasts are multinucleated cells of he-
mopoietic origin that are responsible for bone resorp-
tion during physiological bone remodeling and in a va-
riety of bone diseases. Osteoclast development requires 
direct heterotypic cell–cell interactions of the hemopoi-
etic osteoclast precursors with the neighboring osteo-
blast/stromal cells. However, the molecular mecha-
nisms underlying these heterotypic interactions are 
poorly understood. We isolated cadherin-6 isoform, de-
noted cadherin-6/2 from a cDNA library of human os-
teoclast-like cells. The isolated cadherin-6/2 is 3,423 bp 
in size consisting of an open reading frame of 2,115 bp, 
which encodes 705 amino acids. This isoform lacks 85 
amino acids between positions 333 and 418 and con-
tains 9 different amino acids in the extracellular domain 
compared with the previously described cadherin-6. 
The human osteoclast-like cells also expressed another 
isoform denoted cadherin-6/1 together with the cad-
herin-6. Introduction of cadherin-6/2 into L-cells that 
showed no cell–cell contact caused evident morphologi-
cal changes accompanied with tight cell–cell associa-
tion, indicating the cadherin-6/2 we isolated here is 
functional. Moreover, expression of dominant-nega-
tive or antisense cadherin-6/2 construct in bone mar-
row–derived mouse stromal ST2 cells, which express 
only cadherin-6/2, markedly impaired their ability to 
support osteoclast formation in a mouse coculture 
model of osteoclastogenesis. Our results suggest that 
cadherin-6 may be a contributory molecule to the het-
erotypic interactions between the hemopoietic osteo-
clast cell lineage and osteoblast/bone marrow stromal 
cells required for the osteoclast differentiation. Since 
both osteoclasts and osteoblasts/bone marrow stromal 
cells are the primary cells controlling physiological 
bone remodeling, expression of cadherin-6 isoforms in 
these two cell types of different origin suggests a critical 
role of these molecules in the relationship of osteoclast 
precursors and cells of osteoblastic lineage within the 
bone microenvironment.
 
M
 
ultinucleated
 
 osteoclasts are unique cells that
are responsible for bone resorption during phys-
iological bone remodeling and in a variety of
bone diseases such as osteoporosis, Paget’s disease, and
osteolytic bone metastasis of cancer (for review see Rood-
man, 1996). Hemopoietic stem cells give rise to osteoclasts
through a series of sequential steps that are under the in-
fluence of diverse hormones, cytokines, and growth fac-
tors. One critical step in osteoclast formation is the fusion
of hemopoietic mononuclear precursors to form multinu-
cleated osteoclasts. We have previously reported that this
fusion step requires homotypic (between the same cells)
cell–cell interactions between the osteoclast precursors
and is mediated by E-cadherin (Mbalaviele et al., 1995). In
addition to homotypic interactions, it has been demon-
strated that osteoclast development also requires direct
cell–cell interactions of the osteoclast precursors with
neighboring cells of the osteoblast/stromal lineage (for re-
view see Suda et al., 1992). These heterotypic (between
two different cell types) interactions could be mediated
through either homophilic (between the same molecules),
heterophilic (between two different molecules) or both.
However, the precise molecular mechanisms underlying
these heterotypic cell–cell interactions are unknown.
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Recently, a previously unrecognized property of cad-
herins has been reported. In the association between lym-
phocytes and intestinal mucosal epithelium, E-cadherin–
expressed mucosal epithelial cells were found to bind with
the integrin 
 
a
 
E
 
b
 
7
 
 (human) (Cepek et al., 1994) or
 
a
 
M290
 
b
 
7 (mouse) (Karecla et al., 1994) expressed in the
lymphocytes. These findings suggest that cadherins are
also able to establish heterotypic or heterophilic cell–cell
interactions. In the present study, we explored the possi-
bility of mediation by cadherins of heterotypic cell-to-cell
communication between the osteoclast precursors and os-
teoblast/stromal cells. Our previous study has demon-
strated that none of the classical cadherins such as epithe-
lial, neural, and placental (E-, N-, and P-) cadherin are
expressed concomitantly in both cell types during osteo-
clastogenesis (Mbalaviele et al., 1995). The present study
was, therefore, first aimed to identify a novel cadherin
member that is expressed both in the osteoclast precursors
and osteoblast/stromal cells. Second, we then determined
its role in osteoclast development in a mouse coculture
model of osteoclastogenesis.
 
Materials and Methods
 
Mouse Bone Marrow Cell Culture
 
We used a well-characterized mouse bone marrow cell culture technique
(Takahashi et al., 1988) to obtain multinucleated osteoclast-like cells.
Mouse bone marrow cells containing mononuclear hemopoietic cells and
stromal cells were collected from femora and tibia of C57BL mice (male,
4–6-wk-old; Harlan Industries, Houston, TX). Cells were washed twice
with serum-free 
 
a
 
MEM (Hazleton Biologies Inc., Lenexa, KS) and cul-
tured in 
 
a
 
MEM supplemented with 10% FBS (Hyclone Laboratories, Lo-
gan, UT), and 10 nM 1,25-dihydroxyvitamin D
 
3
 
 (1,25D
 
3
 
)
 
1
 
 (BIOMOL, Ply-
mouth Meeting, PA) in 48-well plates (Falcon, Becton Dickinson
Labware, Lincoln Park, NJ) (10
 
6
 
 cells/0.5 ml/well) for 6 d at 37
 
8
 
C in a hu-
midified atmosphere of 5% CO
 
2
 
 in air. At day 2 of the culture when most
of cells did not become adherent yet, medium change was not done but 0.5
ml fresh 
 
a
 
MEM containing 10% FCS, 20 nM 1,25D
 
3 
 
was added to the cul-
tures. At day 4 when majority of cells attached, 0.5 ml of the culture me-
dium was gently aspirated without agitating non-adherent cells, and then
0.5 ml fresh 
 
a
 
MEM-containing factors was added. At the end of the cul-
ture, cells were fixed in 60% acetone in citrate buffer, pH 5.4, for 30 s,
washed twice with distilled water, air dried, and then stained for tartrate-
resistant acid phosphatase (TRAP), a widely used cytochemical marker of
mouse osteoclasts (Wijngaert and Burger, 1986), using a commercially
available kit (Sigma Chemical Co., St. Louis, MO). Stained cultures were
examined under light microscopy at a magnification of 
 
3
 
200. TRAP-posi-
tive (red-staining) multinucleated (three or more nuclei) cells (osteoclast-
like cells) in each well were counted by manually scanning across the en-
tire well in a systematic fashion (Mbalaviele et al., 1995). It should be
noted that multinucleated osteoclast-like cells supported by stromal cells
are developed only in the presence of 1,25D
 
3 
 
in this culture system. In the
absence of 1,25D
 
3
 
, no multinucleated osteoclast-like cells are formed
 
 
 
and
there is only a mixture of mononuclear hemopoietic cells and stromal cells
in the cultures.
 
RNA Preparation
 
Highly purified human mature osteoclast-like cells were isolated from gi-
ant cell tumors of bone. Highly purified human bone marrow hematopoie-
tic CD34
 
1
 
 progenitors (purity 
 
.
 
95%) were purchased from Poietic Tech-
nologies, Inc. (Gaithersburg, MD) and used straightforward for RNA
isolation. CD34
 
1
 
 progenitors have been shown to contain pools of osteo-
clast precursors (Matayoshi et al., 1996; Pierelli et al., 1997). Primary
mouse bone marrow cells (10
 
6 
 
cells/cm
 
2
 
, 10-cm dish) containing hemopoie-
 
tic mononuclear cells and stromal cells were cultured for 6 d in the pres-
ence of 10 nM 1,25D
 
3
 
 to generate osteoclast-like cells. Human osteoblastic
cell lines (5 
 
3 
 
10
 
5
 
 cells/well, 6-well plates) were cultured for 3–4 d until
confluency.
 
 
 
Total RNA was extracted with
 
 
 
guanidinium thiocyanate using
protocols based on the commercial product RNAzol according to the
manufacturer’s directions (Cinna/Biotecx Laboratories, Inc., Houston, TX).
 
PCR Techniques and DNA Analysis
 
To search for novel cadherins, PCR was performed on a cDNA library
prepared from highly purified human osteoclast-like cells (Takahashi et al.,
1994) using two degenerate oligonucleotide primers. These primers were
designed based on the highly conserved cytoplasmic domain of known
cadherins as previously described by Suzuki et al. (1991). PCR was per-
formed for 35 cycles consisting of denaturation at 94
 
8
 
C for 10 min, anneal-
ing at 50
 
8
 
C for 2 min, and then polymerization at 72
 
8
 
C for 3 min. PCR
products were size fractionated by agarose gel electrophoresis and compo-
nents of 
 
z
 
160 bp were extracted, ligated into PCR™II (Invitrogen, San
Diego, CA), sequenced, and then used as probes to isolate full-length
cDNA from the same library. Nucleotide sequencing of both strands of
cloned PCR products and full cDNA clones was performed by the double-
strand dideoxy-chain termination method, using T7 polymerase (Seque-
nase version 2.0; United States Biochemical Corp., Cleveland, OH). The
nucleotide and amino acid sequences were analyzed using the Genepro™
software (Riverside Scientific Enterprises, Bainbridge Island, WA).
PCR detection of the alternatively spliced isoforms of cadherin-6 was
performed either on human osteoclast-like cell cDNA library as described
above or on reverse-transcribed single-strand cDNA from total RNA
preparations (1 
 
m
 
g) using Moloney murine leukemia virus reverse tran-
scriptase and random hexamers primers (Perkin Elmer Cetus, Norwalk,
CT). The upstream primer 5
 
9
 
-CAGATGGGAGGATTATCTGGG-3
 
9
 
(positions 760–781 bp; see Fig. 4) and the downstream primer 5
 
9
 
-GTA-
CTCGACTACTTTGCTTTGGATT-3
 
9
 
 (positions 1,169–1,194 bp) were
designed to amplify fragments encompassing the alternative splicing site.
PCR was carried out as described above except that the denaturation was
at 94
 
8
 
C for 1.5 min. The components of predicted size were extracted from
agarose gel, ligated into PCR™II, and then sequenced.
Reverse transcription (RT)-PCR detection of cadherin-6/2 (see below
for the designation of cadherin-6/2) antisense products from those of cad-
herin-6/2 sense was performed using the upstream primer 5
 
9
 
-CACTAT-
AGGCTAGCCTCGAG-3
 
9
 
, which bound to the untranslated sequences
of T7 promoter of pCIneo, and the downstream primer 5
 
9
 
-GAGTTCA-
GTGGAGAGGTTAGAGCC-3
 
9
 
 specific for cadherin-6/2.
Competitive RT-PCR on total RNA from ST2 cells transfected with
truncated cadherin-6/2 (cadherin-6/2DE) (see below for the truncation of
cadherin-6/2) was performed using SuperScript™ RNase H reverse tran-
scriptase (Gibco Laboratories, Grand Island, NY). PCR was performed in
the presence of different concentrations (0.00001–10 fmol) of a homolo-
gous competitor DNA using PCR SuperMix (Gibco Laboratories, Grand
Island, NY). To distinguish amplified cadherin-6/2 fragments from those
of cadherin-6/2DE, the primers were designed as follows: the downstream
primer 5
 
9
 
-TGACCACAGGCAAGAGATAGG-3
 
9
 
 annealed both the en-
dogenous cadherin-6/2 and cadherin-6/2DE, as well as the competitor. The
upstream primers 5
 
9
 
-CAGATGGGAGGATTATCTGGG-3
 
9
 
 and 5
 
9
 
-CAC-
TATAGGCTAGCCTCGAG-3
 
9
 
 in addition to the competitor, specifically
annealed the endogenous cadherin-6/2 and the untranslated sequences of
T7 promoter of pCIneo vector containing cadherin-6/2DE, respectively.
 
Expression Vectors
 
An expression vector for cadherin-6/2 (pCIneo-cadherin-6/2) was con-
structed by isolating the full-length cadherin-6/2 cDNA from pBlueScript
by digestion with XhoI–NotI, which was then inserted into the XhoI/NotI
sites of pCIneo vector (Promega Corp., Madison, WI).
The expression vector for cadherin-6/2 truncated of its extracellular do-
main (pCIneo–cadherin-6/2DE) was made as follows: pCIneo–cadherin-
6/2 was digested with XhoI–NotI to release full-length cadherin-6/2 and
subsequently digested with SphI to generate a SphI–NotI fragment, 282-
bp upstream of the transmembrane domain of cadherin-6/2 (see Fig. 3). In
parallel, the upstream primer 5
 
9
 
-CACTATAGGCTAGCCTCGAG-3
 
9
 
 and
the downstream primer 5
 
9
 
-GCATGCGCTGGGAAACCACTAGTCCT-3
 
9
 
were designed to contain the sites of XhoI (at 5
 
9
 
 end) and SphI (at 3
 
9
 
 end),
respectively, and amplify a fragment of 129 bp using the putative signal
peptide and precursor sequences of cadherin-6/2 as a template. The frag-
ment was then cloned into PCR™II vector, sequenced and released by
 
1. 
 
Abbreviations used in this paper
 
: 1,25D
 
3
 
, 1,25-dihydroxyvitamin D
 
3
 
;
GST, glutathione-S-transferase; RT, reverse transcription. 
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XhoI–SphI digestion to generate a XhoI–SphI fragment. XhoI–SphI and
SphI–NotI fragments that were in-frame were ligated into pCIneo vector,
previously digested with XhoI–NotI.
For the cadherin-6/2 antisense construct, pCIneo-cadherin-6/2 was first
digested with XhoI–NotI, the vector and the insert was filled in, and then
the blunt end was ligated. The antisense orientation was checked by diges-
tion with appropriate enzymes.
To generate glutathione-S-transferase (GST)–cadherin-6/2DC fusion
protein for antibody production, the extracellular domain of cadherin-6/2
(see Fig. 4 
 
B
 
) was amplified using two oligonucleotide primers. The up-
stream primer 5
 
9
 
-CCCCAAGCTTTGGAATCAGTTCTTTCTCCTG-
GAA-3
 
9
 
 overlapped the BamHI site of cadherin-6/2 and the same restriction
site was included in the downstream primer 5
 
9
 
-CCCCAAGCTTAGAT-
AGGTGCTCATCTCGTGTC-3
 
9
 
. The amplified fragment was digested
with BamHI and inserted into the BamHI site of pGSTag in frame with
GST to generate the recombinant protein designated GST–cadherin-6/2DC.
GST–cadherin-6/2DC was expressed in BL-21 (Stratagene, La Jolla, CA).
The bacteria were grown in 2YT medium supplemented with 50 
 
m
 
g/ml
ampicillin. Expression of the recombinant protein was induced with 0.3
mM IPTG for 1 h at 37
 
8
 
C at OD
 
600
 
 of 1. The bacteria were pelleted and re-
suspended in PBS containing 1 mM PMSF and 10 mM EDTA. The bacte-
ria were lysed by sonication at 4
 
8
 
C for 20 s. Cell debris was removed by
centrifugation (10 min, 14,000 
 
g
 
). GST fusion protein was purified by
chromatography on glutathione-agarose (Sigma Chemical Co.), eluted
from the beads with 10 mM of reduced glutathione in 50 mM Tris-HCl,
pH 8.0.
 
DNA Transfection
 
L929 cells (American Type Culture Collection, Rockville, MD) or stromal
ST2 cells were grown in DME and 
 
a
 
MEM supplemented with 10% FBS
and 1% penicillin-streptomycin, respectively. The cells were transfected
with DNA by the standard calcium phosphate coprecipitation method.
After 24 h of incubation, cells were fed with fresh medium, grown for fur-
ther 24 h, split and seeded into 100-mm dishes, and then cultured in the
presence of 250 
 
m
 
g/ml (ST2 cells) or 400 
 
m
 
g/ml (L929 cells) antibiotic
G418 (Gibco Laboratories, Grand Island, NY). G418-resistant colonies
were isolated and analyzed for recombinant protein expression.
 
Antibody Production
 
The purified recombinant protein GST–cadherin-6/2DC bound to glu-
tathione-agarose beads was digested with human plasma thrombin (Sigma
Chemical Co.) (ratio 1,000:1) at room temperature for 4 h. The thrombin
digestion site is located between GST and the cloning site of pGSTag. The
released cadherin-6/2DC fragment was separated from GST–glutathione-
agarose by centrifugation at 14,000 
 
g
 
 for 10 min, and then used to immu-
nize rabbits for the generation of polyclonal antibody to cadherin-6/2DC.
Mouse mAb to rat K-cadherin (also known as cadherin-6) and 
 
b
 
-cate-
nin were purchased from Transduction Laboratories (Lexington, KY).
The mouse mAb recognizing N-cadherin (13A9), but not P-, E-, or muscular
(M)-cadherin (Donalies et al., 1991) was kindly provided by Dr. Whee-
lock (University of Toledo, Toledo, OH). Mouse mAb to pan cadherin was
purchased from Sigma Chemical Co. This antibody recognizes cadherins con-
taining the COOH-terminal cadherin tail, regardless of their cadherin type.
 
Immunoprecipitation and Immunoblotting
 
Cells were lysed in a buffer containing 20 mM Tris-HCl, pH 8.0, 2 mM
CaCl
 
2
 
, 150 mM NaCl, 1% NP-40, 0.1% SDS, and protease inhibitors (20 mM
leupeptin, 1 mM PMSF, 1% aprotinin solution) at 4
 
8
 
C, and then centri-
fuged at 10,000 
 
g
 
 for 10 min at 4
 
8
 
C. The protein content of the superna-
tants was determined using the DC protein assay (Bio-Rad Laboratories,
Hercules, CA), and the samples were then incubated with antibody for 2 h
at 4
 
8
 
C. Protein A–Sepharose beads (Zymed Laboratories, South San
Francisco, CA) were added to the mixtures and incubated for an addi-
tional 2 h. Beads and associated immune complexes were washed three
times with lysis buffer. The immunoprecipitates were resuspended in
SDS-PAGE sample buffer, boiled for 5 min, resolved on 7.5% Laemmli
gels, and then processed for immunoblotting as follows.
The proteins were transferred onto polyvinyldine difluoride mem-
branes (Immobilon-P; Millipore Corp., Bedford, MA) in transblotting
buffer containing 20 mM Tris, 150 mM glycine, and 20% methanol, pH
8.0. The membranes were incubated overnight with blocking buffer con-
sisting of 5% nonfat dry milk (Carnation Company, Los Angeles, CA) in
 
TBS (50 mM Tris-HCl, 150 mM NaCl), and then with antibody diluted in
the same buffer for 2 h, washed once with TBS containing 0.05% Tween
20 (TBST), and then twice with TBS, incubated for 1 h with HRP-conju-
gated secondary antibody or HRP-conjugated protein A, diluted in TBS
containing 5% nonfat dry milk. After the membranes were washed three
times with TBST, and then three times with TBS, the signal was visualized
with ECL detection system (DuPont NEN, Boston, MA).
 
Immunocytochemistry
 
Mouse marrow cells (10
 
6 
 
cells/cm
 
2
 
) were cultured in the presence of 10 nM
1,25D
 
3 
 
for 6 d to generate osteoclast-like cells, washed twice with PBS,
fixed with a fresh solution of 3.7% (wt/vol) formaldehyde in PBS at room
temperature for 30 min, blocked with 1% goat serum, incubated with pre-
immune or immune serum, at 1:500 dilution in PBS containing 0.1% goat
serum at 37
 
8
 
C for 1.5 h in humidified atmosphere, washed once with
0.05% Tween 20 in PBS, and then twice in PBS. Cells were then incubated
with goat secondary antibody and stained using the Vectastain ABC kit
(Vector Laboratories, Inc., Burlingame, CA).
 
Coculture of Mouse ST2 Cells and Mouse Bone
Marrow Cells
 
Mouse bone marrow cells (100,000 cells) and ST2 cells (5,000 cells) trans-
fected with either empty vector, dominant-negative, antisense, or sense
constructs were mixed in suspension, plated onto 48-well plates, and then
cultured in 
 
a
 
MEM supplemented with 10% FBS, 10 nM 1,25D
 
3
 
, and 100
nM dexamethasone. After 6 d of culture, number of multinucleated osteo-
clast-like cells formed was counted as described above.
 
Statistical Analysis
 
All data were analyzed by analysis of variance, followed by a paired 
 
t
 
 test.
 
Results
 
Cloning and Structural Analysis
 
cDNA Cloning.  
 
To clone cadherins expressed by the os-
teoclast-like cells, PCR was performed on a cDNA library
derived from highly purified human osteoclast-like cells.
PCR products of predicted size of 160 bp were purified,
cloned, and sequenced. One clone was 100% identical to
E-cadherin, confirming our previous finding of E-cadherin
expression by osteoclasts (Mbalaviele et al., 1995). An-
other clone that showed 
 
z
 
60% homology with known
cadherins was used as a probe to isolate a 3,423-bp cDNA
from a cDNA library derived from highly purified human
osteoclast-like cells. The cDNA consisted of an open read-
ing frame of 2,115 bases (coding for 705 amino acids)
flanked by 31 bases of untranslated sequence at the 5
 
9
 
 end
and 1,277 bases at the 3
 
9
 
 end including a stop codon, a
polyadenylation sequence and a polyadenylate tail (Fig.
1). The assigned initiator Met residue was followed by a
typical signal sequence and a precursor peptide.
 
Structure of the Cadherin Protein.  
 
Comparison of the de-
duced full-length amino acid sequence revealed that the
isolated molecule belonged to the cadherin family. The
mature protein structure predicted an extracellular do-
main of 498 amino acids that could be subdivided into five
subdomains, and a hydrophobic transmembrane domain
of 33 amino acids followed by an intracellular domain of
154 amino acids (Fig. 1). When the sequence of the iso-
lated molecule was aligned to that of cadherin family
members, it showed high homology with cadherin-6 (Shi-
moyama et al., 1995), the human counterpart of the rat K-cad-
herin (Xiang et al., 1994). However, the newly cloned mol-
ecule lacked 85 amino acids (255 bp) at positions 333–418 
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and had different amino acid sequence at positions 283–291,
compared with the previously reported cadherin-6 se-
quence (Figs. 2 and 3), suggesting a polymorphism in the
cadherin-6 gene.
 
Expression Analysis
 
mRNA.
 
 
 
 
 
Northern analysis of K-cadherin (Xiang et al.,
1994) and cadherin-6 (Shimoyama et al., 1995; Paul et al.,
1997) demonstrated the presence of three transcripts. It is
unknown if some of these transcripts arise by alternative
splicing, alternate 3
 
9
 
 noncoding regions or different genes.
We therefore chose a PCR approach to address this issue.
PCR was carried out using oligonucleotide primers that al-
lowed the amplification of fragments encompassing the
splicing site. The cDNA library from human osteoclast-
like cells was used as a template. We found an expected
spliced fragment of 433 bp (Fig. 4 
 
A
 
, lane 
 
8
 
), which corre-
sponded to our cDNA clone. In addition, a 688-bp frag-
ment and a novel 615-bp fragment were obtained. The
688-bp fragment was identical to the previously identified
unspliced isoform of cadherin-6 (Shimoyama et al., 1995).
The 433- and 615-bp fragments were likely the alterna-
tively spliced isoforms of cadherin-6. We denoted the un-
spliced isoform as cadherin-6 and the isoforms depleted of
73 and 255 bp as cadherin-6/1 and cadherin-6/2, respec-
tively (Fig. 4, 
 
A
 
 and 
 
B
 
). Both cadherin-6/1 and cadherin-6/2
lacked regions of the extracellular subdomains 3 and 4. We
also confirmed that the three cadherin-6 isoforms were ex-
pressed by highly purified human CD34
 
1
 
 progenitors
which contain pools of osteoclast precursors (Fig. 4 
 
A
 
, lane
2) and osteoclast-like cells derived from giant cell tumors
Figure 1. Nucleotide and deduced amino acid sequence. The cDNA contained non-coding 31 bp at the 59 end (non-coding) followed by
an open reading frame of 2,115 bases. The protein contained a signal peptide (SIG), a precursor peptide (PRE), an extracellular domain
(EC1–EC5), a transmembrane domain (TM) and cytoplasmic domain (CP). The polyadenylation signal and the polyadenylate tail are
shown by single and double underlining, respectively. 
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of bone (Fig. 4 
 
A
 
, lane 5). Human osteoblastic cell lines
MG-63 and TE-85 also expressed these three isoforms
(Fig. 4 A, lanes 7 and 4, respectively). In contrast, we
found that mouse stromal ST2 cells expressed only cad-
herin-6/2 (Fig. 4 C, lane 2). Similarly, mouse bone marrow
cells that were cultured in the presence (multinucleated
osteoclast-like cells and supporting stromal cells were
present in the cultures) (Fig. 4 C, lane 3) or absence (no
multinucleated osteoclast-like cells were formed but there
was a mixture of mononuclear hemopoietic cells and stro-
mal cells in the cultures) (Fig. 4 C, lane 4) of 1,25D3 also
showed an expression of only cadherin-6/2. Moreover, we
found that mouse osteoblastic cell line MC3T3-E1 and rat
osteoblastic cell line ROS 17/2.8 also expressed only cad-
herin-6/2 (Fig. 4 C, lanes 6 and 7, respectively).
Protein.  To determine if the polyclonal antibody recog-
nized cadherin-6/2DC, against which it was raised, recom-
binant GST–cadherin-6/2DC was subjected to SDS-PAGE
and immunoblotting. Fig. 5 shows that the antibody recog-
nized the expected fusion protein of 69 kD (Fig. 5, lane 4)
but not the GST protein (lane 3). The preimmune serum
did not recognize either GST–cadherin-6/2DC (Fig. 5, lane 2)
or GST (lane 1).
Immunoblotting analysis using the commercially avail-
able mAb to cadherin-6 showed an expression of z110–
120 kD protein in the human osteoblastic cell line MG-63
and mouse stromal ST2 cells (Fig. 6 A, lanes 1 and 2, re-
spectively). The band at 110–120 kD was also the only one
detected using polyclonal antibody to cadherin-6/2 or pan
cadherin antibody that recognizes most of the cadherins
described so far (data not shown). Although these anti-
bodies recognize all three cadherin-6 isoforms, the band
visualized in the ST2 cell lysates likely represents cad-
herin6/2, since ST2 showed only cadherin6/2 expression by
RT-PCR (Fig. 4 C, lane 2).
To determine whether cadherin-6 or its isoforms, like
other cadherins, associate with catenins, the lysates of
MG-63 were immunoprecipitated using the antibody to
b-catenin. The antibody to cadherin-6 could not be used
for direct immunoprecipitation experiments. Proteins were
then subjected to SDS-PAGE and immunoblotted with
the mAb to cadherin-6. The result shows that the 110–120
Figure 2. Comparison of the amino acid sequences of mature proteins. The sequence of cadherin-6/2 (bottom) was 100% identical to
that of cadherin-6 (top) except that the new cadherin was depleted of 85 amino acids from position 282–367 in cadherin-6. In addition, 9
amino acids at position 283–291 (CRSTHRYGQ) in cadherin-6/2 were different to those of cadherin-6. EC, extracellular domain; TM,
transmembrane domain; CP, cytoplasmic domain.
Figure 3. Truncation of the extracellular domain of cadherin-6/2
(cadherin-6/2DE). Cadherin-6/2DE contains SphI recognition
site at position 1,933–1,938 bp (bold). To delete the most extra-
cellular domain of cadherin-6/2, SphI site was created at position
130–135 bp (bold) of cadherin-6/2 by PCR as described in Materi-
als and Methods. Note that the creation of SphI site generated 3
amino acids designated X, which are Ala-His-Ala. EC, extracel-
lular domain; TM, transmembrane domain; CP, cytoplasmic do-
main.The Journal of Cell Biology, Volume 141, 1998 1472
kD protein coimmunoprecipitated with b-catenin (Fig. 6
B, lane 1). When the same membrane was stripped off and
re-blotted with the mAb to b-catenin, an expected band at
85 kD, which corresponded with the molecular size of
b-catenin was observed (Fig. 6 B, lane 2). In ST2 cells that
expressed only cadherin-6/2 (Fig. 4 C, lane 2), the cad-
herin-6/2 also coimmunoprecipitated with b-catenin (Fig.
6 C, lane 1, and D, lane 4). To confirm cadherin-6 protein
expression in osteoclast cell lineage and stromal cells,
mouse bone marrow cells were cultured for 6 d in the pres-
ence of 10 nM 1,25D3 to form multinucleated osteoclast-
like cells. The polyclonal antibody to cadherin-6 was used
in this experiment because the mAb to cadherin-6 could
not be used for immunocytochemical analysis of mouse
cells because of high background. As shown in Fig. 7,
multinucleated osteoclast-like cells as well as mononuclear
cells with round (hemopoietic cells) and spindle (stromal
cells) shapes exhibited the reactivity to the cadherin-6 an-
tibody. Although this polyclonal antibody recognizes all
three cadherin-6 isoforms, it is likely that the immunocy-
tochemical stain displayed in these cells represents cad-
herin-6/2, since RT-PCR data showed that only cadherin-
6/2 was expressed in mouse marrow cultures (Fig. 4 C, lane
2). The result indicates that both cells of the osteoclast lin-
eage and stromal cells in the mouse bone marrow cultures
express cadherin-6/2.
Functional Analysis
Cell–Cell Adhesion Function of Cadherin-6/2.  To examine
whether the cadherin-6/2 we identified induces cell–cell
adhesion, mouse fibroblasts L cells that normally do not
Figure 4. (A) RT-PCR analysis of cadherin-6 gene expression. Human osteoblastic cell line MG-63 (lane 7); a cDNA library of human
osteoclast-like cells (lane 8); highly purified human bone marrow CD341 progenitors (lane 2); human mature osteoclast-like cells de-
rived from giant cell tumors of bone (lane 5); and TE-85 (lane 4). 1-kb (lane 1) and 123-bp (lanes 3 and 6) DNA ladders, respectively.
(B) Occurrence of alternative splicing in cadherin-6 gene. Cadherin-6/2 contains an extracellular domain (EC1 to EC5), a transmem-
brane domain (TM) and a cytoplasmic domain (CP). Comparison of amino acid sequences of PCR products to those of cadherin-6 sug-
gested an alternative splicing reaction involving regions of EC3 and EC4 to generate cadherin-6/1 (Splicing 1). Another splicing in-
volved the same sequences of EC3 and other sequences of EC4 to generate cadherin-6/2 (Splicing 2). Horizontal arrows below cadherin-6
and cadherin-6/2 indicate the location of primers used to analyze the alternative splicing and amplify the extracellular domain of cad-
herin-6/2 for polyclonal antibody production, respectively. (C) RT-PCR analysis of cadherin-6 gene expression in mouse and rat cells. A
123-bp DNA ladder (lanes 1 and 5); mouse stromal ST2 cells (lane 2); mouse bone marrow cells cultured in the presence (multinucle-
ated osteoclast-like cells and supporting stromal cells were present in the cultures) (lane 3) or absence (no multinucleated osteoclast-like
cells were formed and mononuclear hemopoietic cells and stromal cells were present in the cultures) (lane 4) of 1,25D3; mouse osteo-
blastic cell line MC3T3-E1 (lane 6); and rat osteoblastic cell line ROS 17/2.8 (lane 7).
Figure 5. Expression of
GST–cadherin-6DC fusion
protein. The extracellular do-
main of human cadherin-6/2
(cadherin-6/2DC) (Fig. 4)
was used to generate poly-
clonal antibody. GST (lanes
1 and 3) or GST–cadherin-
6/2DC fusion protein (lanes
2 and 4) were expressed in
Escherichia coli and purified
by affinity chromatography.
After SDS-PAGE and trans-
blotting, the membrane was
incubated with the preim-
mune serum (lanes 1 and 2)
or polyclonal antibody to
cadherin-6/2DC (lanes 3 and
4). An expected 6-kD fusion protein was recognized by the anti-
body but not by the preimmune serum. The antibody showed no
cross-reaction with the GST protein. The smaller fragment was
likely a proteolytic product.Mbalaviele et al. Cadherin-6 in Osteoclastogenesis 1473
express endogenous cadherins and do not display tight
cell–cell contact (Nakagawa et al., 1995) were stably trans-
fected with cadherin-6/2 and determined for cadherin-6/2
expression and cell–cell contact. Several G418-resistant
clones of L-cells that expressed cadherin-6/2 (Fig. 8 B, Af-
ter) showed polygonal shape and tight cell–cell contact
(Fig. 8 A, After).
Role of Cadherin-6/2 in Osteoclast Differentiation; the Ef-
fect of Dominant-Negative Cadherin-6/2 (Cadherin-6/2DE).
Mouse stromal ST2 cells are well characterized for their
ability to support osteoclast differentiation in coculture
with the mononuclear osteoclast precursors (Takahashi
et al., 1988). As shown above, ST2 cells expressed cad-
herin-6/2 by RT-PCR (Fig. 4 C, lane 2) and immunoblot-
ting (Fig. 6). We, therefore, attempted to determine the
role of cadherin-6/2 in osteoclastogenesis through interfer-
ing with the function of cadherin-6/2 in ST2 cells. ST2 cells
were stably transfected with cadherin-6/2 depleted of its
extracellular domain (cadherin-6/2DE), and then exam-
ined for the ability to support osteoclast differentiation.
Because all antibodies to cadherin-6 were raised against its
extracellular domain, competitive RT-PCR analysis was
used to select ST2 clones overexpressing cadherin-6/2DE.
We isolated several clones in which the levels of cadherin-
6/2DE was .100-fold higher compared with those of en-
dogenous cadherin-6/2 (Fig. 9).
Overexpressed cadherin-6/2DE, which is truncated of its
extracellular domain should compete with endogenous
cadherin-6/2 for the binding to catenins as has been de-
scribed for other truncated cadherins (Kintner, 1992). To
confirm this, the cell lysates of ST2 cells overexpressing ei-
ther empty vector or cadherin-6/2DE were coimmunopre-
cipitated with the mAb to b-catenin. The membranes were
blotted with the mAb to cadherin-6, which recognizes only
endogenous cadherin-6/2 but not transfected truncated
cadherin-6/2DE since this antibody was raised against the
extracellular domain of cadherin-6. As shown above, en-
dogenous cadherin-6/2 coimmunoprecipitated with b-cate-
nin in ST2 cells transfected with empty vector (Fig. 6 C,
lane 1), whereas it failed to bind with b-catenin in the two
different clones of ST2 cells overexpressing cadherin-6/2DE
(Fig. 6 C, lanes 2 and 3). The polyclonal antibody to cad-
herin-6/2 that we generated, produced identical results
(Fig. 6 D, lane 4, empty vector; and lane 5, cadherin-6/2DE).
Because the cadherin-6/2DE most likely competes for the
binding to b-catenin with all cadherin-6 isoforms, these
data indicate that transfected cadherin-6/2DE had a domi-
nant-negative effect on the binding of the endogenous
cadherin-6. However, since ST2 cells express only cad-
herin-6/2 based on the RT-PCR data (Fig. 4 C, lane 2), it is
probable that cadherin6/2 binding to b-catenin was inter-
fered by the cadherin6/2DE in case of ST2 cells.
Transfection of cadherin-6/2DE did not alter the mor-
phology and growth of ST2 cells. Furthermore, ST2 cells
overexpressing cadherin-6/2DE showed an increase in al-
kaline phosphatase expression in response to retinoic acid
as did nontransfected ST2 cells (data not shown). Stimula-
tion of alkaline phosphatase activity by retinoic acid has
been shown to be a critical property of ST2 cells that re-
tain the ability to support osteoclast differentiation (Taka-
Figure 6. (A) Immunoblotting analysis of cadherin-6 protein ex-
pression. Confluent MG-63 (lane 1) or ST2 (lane 2) were lysed
and subjected to immunoblotting. An an z110–120 kD protein
was recognized by the mAb to cadherin-6. (B) Coimmunoprecip-
itation of cadherin-6 and b-catenin in human osteoblastic cell line
MG-63. MG-63 lysates were immunoprecipitated using b-catenin
antibody and immunoblotted using the mAb to cadherin-6. The
expected 110–120 kD protein was detected (lane 1). The same
membrane was stripped off and then reblotted with the b-catenin
antibody. Note a protein at 85 kD corresponding to b-catenin
(lane 2). (C and D) Effects of cadherin-6/2DE on the association
of cadherin-6 and b-catenin. Mouse stromal ST2 cells transfected
with empty vector (lanes 1 and 4) or cadherin-6/2DE (lanes 2, 3,
and 5) were lysed and immunoprecipitated using b-catenin anti-
body, subjected to SDS-PAGE, and then blotted with mono-
clonal cadherin-6 antibody (C) or polyclonal antibody to cad-
herin-6/2 (D).
Figure 7.  Immunocytochem-
ical analysis of cadherin-6
gene expression. Mouse bone
marrow cells containing
mononuclear hemopoietic
cells and stromal cells were
treated with 10 nM 1,25D3
and 100 nM dexamethasone
for 6 d. The cultures contain-
ing multinucleated osteo-
clast-like cells, mononuclear
hemopoietic cells and stro-
mal sells were then incubated
with the polyclonal antibody
to cadherin-6/2. Multinucle-
ated osteoclast-like cells (ar-
rows) and mononuclear cells (asterisks) with round (hemopoietic cells) or spindle (stromal cells) were positively stained by the cadherin-
6/2 antibody (left) but not by the preimmune serum (right).The Journal of Cell Biology, Volume 141, 1998 1474
hashi et al., 1988). These results suggest that, at least, the
phenotype of ST2 cells required for a support of osteoclas-
togenesis is not altered by cadherin-6/2DE transfection.
When ST2 cells overexpressing cadherin-6/2DE were coc-
ultured with mouse bone marrow cells containing mono-
nuclear osteoclast precursors for 6 d in the presence of 10 nM
1,25D3, multinucleated osteoclast-like cell formation was
decreased by .70% (Fig. 10, left). Three different clones
overexpressing cadherin-6/2DE showed identical effects
(data not shown). These data suggest that cadherin-6/2,
which is the only cadherin-6 isoform expressed in ST2 cells
(Fig. 4 C, lane 2), is involved in interactions between stro-
mal ST2 cells and osteoclast precursors in the formation of
osteoclast-like cells in this coculture model.
Effects of Cadherin-6/2 Antisense on Osteoclast-like Cell
Formation. It seems likely that cadherin-6/2DE shows a
dominant-negative effect on all the endogenous cadherins
that associate with catenins. Therefore, the effect observed
above may not be due to a dominant-negative effect spe-
cific for cadherin-6/2. To specifically target cadherin-6/2,
ST2 cells were next transfected with a cadherin-6/2 anti-
sense construct. Positive clones for antisense expression
were identified by RT-PCR as described in Materials and
Methods (data not shown). Cadherin-6/2 antisense expres-
sion had no effect on ST2 cell morphology, growth, and al-
kaline phosphatase expression (data not shown). How-
ever, when ST2 cells expressing the cadherin-6/2 antisense
construct were cocultured with mouse bone marrow cells
containing mononuclear osteoclast precursors, the ability
of ST2 cells to support multinucleated osteoclast-like cell
formation was decreased by .50% (Fig. 10, right). These
data strongly suggest that cadherin-6/2 plays a critical role
in osteoclast-like cell formation in this coculture model.
Discussion
In this study we report the isolation of cadherin-6 isoform
Figure 8. Effect of cadherin-6/2 transfection into mouse fibroblast L929 cells. L929 cells were stably transfected either with empty vec-
tor or cadherin-6/2 expression vector. Transfected cells expressed cadherin-6/2 detected by immunoblotting (B, After) and showed
strong cell–cell adhesiveness (A, After) compared with non-transfected cells (A, Before).
Figure 9. Competitive RT-PCR analysis of cadherin-6/2 expres-
sion. Lanes 1–8 on left and on right of the vertical bar, represent
empty vector- and cadherin-6/2DE–transfected ST2 cells, respec-
tively. PCR was performed in the presence of decreasing concen-
trations of the competitor DNA (arrowhead) (10; 1; 0.1; 0.01;
0.001; 0.0001; 0.00001; 0 fmol). Lanes a and b, 123-bp DNA lad-
der. Note that endogenous cadherin-6/2 (arrow) was no longer
amplified in the presence of 0.001 fmol of competitor versus 1
fmol in the case of cadherin-6/2DE (spotted arrow).
Figure 10. (Left) Effects of the expression of cadherin-6/2DE on
multinucleated osteoclast-like cell formation. Mouse bone mar-
row cells containing mononuclear hemopoietic cells and stromal
cells were cocultured with stromal ST2 cells stably transfected
with empty vector or cadherin-6/2DE for 6 d in the presence of
10 nM 1,25D3 and 100 nM dexamethasone. ST2 cells expressing
cadherin-6/2DE (open bar) showed decreased ability to support
multinucleated osteoclast-like cell formation compared with
empty vector–transfected control cells (closed bar). Data shown
are mean 1 SE (n 5 4, for three experiments). Asterisk, signifi-
cantly different from control (P , 0.05). (Right) Effect of cad-
herin-6/2 antisense on multinucleated osteoclast-like cell for-
mation. Mouse bone marrow cells containing mononuclear
hemopoietic cells and stromal cells were cocultured with stromal
ST2 cells stably transfected with sense or cadherin-6/2 antisense
for 6 days in the presence of 10 nM 1,25D3 and 100 nM dexam-
ethasone. ST2 cells expressing cadherin-6 antisense (open bar)
showed decreased ability to support multinucleated osteoclast-
like cell formation compared with sense-transfected control cells
(closed bar). Data shown are mean 1 SE (n 5 4, for three experi-
ments). Asterisk, significantly different from control (P , 0.05).Mbalaviele et al. Cadherin-6 in Osteoclastogenesis 1475
from the cDNA library of human osteoclast-like cells, the
principal cells responsible for bone resorption during
physiological bone resorption and a variety of bone dis-
eases (for review see Roodman, 1996). Although isolation
of cadherin-6 in human cancer (Shimoyama et al., 1995;
Shimazu et al., 1996), chick embryo (Nakagawa et al.,
1995; Inoue et al., 1997), and its rat homologue K-cadherin
(Xiang et al., 1994) has been reported previously, here we
describe the isolation of the identical gene in the human
normal mature osteoclast-like cells that have distinctive
physiological and pathological functions. Our RT-PCR
data showed that cadherin-6 isoforms (cadherin-6, cad-
herin-6/1, and cadherin-6/2) are expressed in the human
mature osteoclast-like giant cells as well as in human
CD341 progenitors that contain pools of osteoclast pre-
cursors. We then studied the biological functions of the
cadherin-6 in a well-characterized murine co-culture
model in which osteoclast-like cells form under the hetero-
typic cooperation between the hemopoietic osteoclast pre-
cursors and osteoblasts/stromal cells (Takahashi et al.,
1988). Our immunohistochemical result together with RT-
PCR data suggests that both osteoclast-like cells and os-
teoblasts/stromal cells express cadherin-6/2 in this murine
culture model. Of note, however, cadherin-6 and cadherin-
6/1 were not detected by RT-PCR in these two types of
mouse cells. The sole expression of cadherin-6/2 in both
hemopoietic cells of osteoclast lineage and bone marrow
stromal cells raises a possibility that cadherin-6/2 may be a
critical cell adhesion molecule (CAM) in osteoclastogene-
sis in mouse. It has been shown that osteoclast generation
requires heterotypic cell–cell contact between the he-
mopoietic osteoclast precursors and bone marrow–derived
stromal cells such as ST2 cells using the similar coculture
model to that used here (Takahashi et al., 1988). ST2 cells
are known to possess the ability to support osteoclast gen-
eration through cell–cell contact and, thus, have been fre-
quently used in the coculture (Takahashi et al., 1988).
Consistent with these earlier results, disruption of cad-
herin-6/2 function or expression with a dominant-negative
or an antisense cadherin-6/2 construct, respectively, in the
ST2 cells suppressed osteoclast formation in the coculture.
It is, therefore, likely that cadherin-6/2 is the primary cad-
herin-6 responsible for establishing the heterotypic inter-
action in this mouse culture model. We did not study the
role of other cadherin-6 isoforms, namely cadherin-6 and
cadherin6/1 in the present study, since these cadherin-6
isoforms were not detected in mouse cells. However, it
should be noted that these isoforms were isolated from a
human osteoclast-like cell cDNA library and detected in
highly purified human CD341 progenitors, which contain
pools of osteoclast precursors and mature osteoclast-like
cells derived from giant cell tumors of bone and human os-
teoblastic cell lines MG-63 and TE-85. Thus, it is probable
that these isoforms also play a critical role in mediating
heterotypic cell–cell interactions in osteoclastogenesis in
human. An establishment of human osteoclast-like cell
line will greatly facilitate to approach this issue. We have
already reported that E-cadherin mediation of homotypic
interactions between hemopoietic mononuclear osteo-
clast precursors is a prerequisite for the fusion to form
multinucleated osteoclasts (Mbalaviele et al., 1995). Since
osteoclasts and osteoblasts are the key cellular component
in physiological bone remodeling, our data suggest that
cadherins including E-cadherin and cadherin-6 may play
an important role in the maintenance of the bone microen-
vironment through mediation of homotypic and hetero-
typic cell–cell interactions. The result, thus, suggests that
cadherins are one of CAMs that modulate cellular cross-
talk between bone cells of different origin in the bone
marrow cavity. It is most likely that heterophilic mediation
between hemopoietic osteoclast precursors and osteo-
blasts/stromal cells also plays an important role in the gen-
eration of osteoclasts. Importance of heterophilic interac-
tions remains to be elucidated.
The molecular mechanisms by which cadherin-6/2 medi-
ates the interactions necessary for osteoclast differentia-
tion are unclear at the present time. However, since we
found that cadherin-6/2 associated with b-catenin, it is
conceivable that the interactions of the hemopoietic osteo-
clast precursors with the stromal ST2 cells through cad-
herin-6/2 may induce activation of intracellular signaling
pathways that involve b-catenin. Recent studies have re-
vealed that b-catenin, which was originally identified as a
bridge between cadherins and cytoskeleton, associates
with DNA binding proteins of the T cell factor–lymphoid
enhancer factor family, and thereby alters gene transcrip-
tion (for review see Miller and Moon, 1996; Korinek et al.,
1997; Morin et al., 1997; Rubinfeld et al., 1997). It is possi-
ble that cadherin-6/2–induced intracellular signaling cas-
cades involving b-catenin may regulate transcription of
genes which encode (a) cytokines in ST2 cells that are re-
quired for the differentiation and survival of the osteo-
clasts. In this context, ST2 cells are known to produce
macrophage colony–stimulating factor (Perkins and Kling,
1995), which is an essential cytokine for osteoclast differ-
entiation (for review see Roodman, 1996); or (b) auto-
crine/intracrine factors in the osteoclast precursors, which
are important for their differentiation. Consistent with this
notion, we found that cadherin-6/2 that was depleted of its
extracellular domain, which inhibits osteoclast formation,
prevented endogenous cadherin-6/2 from binding to b-cate-
nin in ST2 cells. In agreement with our finding, Kintner
(1992) has also shown the impairment of the association of
endogenous cadherins with catenins in Xenopus embryos
in which N-cadherin depleted of its extracellular domain
was overexpressed.
By immunoblotting analysis using cadherin-6 antibodies
of different sources, we consistently observed only a single
broad band of z110–120 kD in MG-63 cells despite the
fact that three cadherin-6 transcripts are present in these
cells. Similar observation has been recently reported by
Paul et al. (1997) using cadherin-6 antibody of another
source. It is most likely that cadherin-6 and cadherin-6/1
may not be distinguishable by immunoblotting because
they only differ by 24 amino acids. Thus, the broad single
band z120–110 kD may represent cadherin-6, cadherin-6/1,
and cadherin-6/2.
We have identified three cadherin-6 isoforms by RT-
PCR, an observation that is consistent with previous re-
ports where three cadherin-6 transcripts were detected by
Northern analysis (Xiang et al., 1994; Shimoyama et al.,
1995; Shimazu et al., 1996; Paul et al., 1997). In contrast,
only cadherin-6/2 was found in cells of mouse origin in-
cluding bone marrow cells and ST2 stromal cells. The al-The Journal of Cell Biology, Volume 141, 1998 1476
ternative splicing reaction generating three cadherin-6 iso-
forms is compatible with the genomic structure of other
cadherins (Berx et al., 1995). In the present study, we only
determined the functional role of cadherin-6/2 in the
mouse model of osteoclastogenesis. It is not known
whether cadherin-6, cadherin-6/1, or cadherin-6/2 has
identical or different roles in the osteoclast development
in human. Loss of 85 amino acids and a 9–amino acid dif-
ference in the extracellular domain may confer altered
functions on cadherin-6/2. However, in a search of the
data bank, neither the sequence of lacking 85 amino acids
nor the 9 different amino acids showed homology with
known molecules that are shown to have biological activ-
ity. This might indicate that cadherin-6 or cadherin-6/1 has
no additional or different functions compared with those
of cadherin-6/2. It remains, however, still possible that
each isoform of cadherin-6 may possess its own unique
function in the regulation of osteoclast formation in the
bone microenvironment. These issues are beyond the scope
of the present study, but need to be examined in the future
experiments.
Finally, the regulatory mechanisms of the splicing reac-
tion generating three variants of cadherin-6 in human os-
teoblastic cells and one variant in mouse osteoblastic and
stromal cells are unknown at the present time. Several dis-
parities have been reported between human and mouse
models of osteoclastogenesis in vitro. Whether the profile
of cadherin-6 gene expression described here contributes
to these differences is not known but may be potentially
an intriguing issue to be pursued.
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